Evidence map›Paper›PMID 34507993›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

IL-6 enhances CD4 cell motility by sustaining mitochondrial Ca

Felipe Valença-Pereira, Qian Fang, Isabelle J Marié, Emily L Giddings, Karen A Fortner, Rui Yang, Alejandro V Villarino, Yina H Huang, David A Frank, Haitao Wen and 2 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. STAT3 axis in cancer and cancer stem cells: From oncogenesis to targeted therapies.Biochimica et biophysica acta. Reviews on cancer · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Mitochondrial metabolism and cancer therapeutic innovation.Signal transduction and targeted therapy · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery.Journal of experimental & clinical cancer research : CR · 2024
    Review
  16. Article
  17. Article
  18. STAT3 modulates CD4Aging cell · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Felipe Valença-PereiraImmunology and Microbiology Department, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
Qian FangImmunology and Microbiology Department, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
Isabelle J MariéDepartment of Pathology, New York University Grossman School of Medicine, New York, NY 10016.
Emily L GiddingsDepartment of Medicine, Immunology Division, University of Vermont, Burlington, VT 05405.ORCID 0000-0002-7682-3949
Karen A FortnerDepartment of Medicine, Immunology Division, University of Vermont, Burlington, VT 05405.
Rui YangDepartment of Medicine, Immunology Division, University of Vermont, Burlington, VT 05405.ORCID 0000-0003-4427-2158
Alejandro V VillarinoMiller School of Medicine, Department of Microbiology and Immunology, University of Miami, Miami, FL 33124.
Yina H HuangDepartment of Microbiology and Immunology, Dartmouth Geisel School of Medicine, Hanover, NH 03755.
David A FrankDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.
Haitao WenDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210.
David E LevyDepartment of Pathology, New York University Grossman School of Medicine, New York, NY 10016.
Mercedes RinconImmunology and Microbiology Department, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; mercedes.rincon@cuanschutz.edu.
University of Vermont · USNew York University · USUniversity of Colorado Anschutz Medical Campus · USDana-Farber Cancer Institute · USDartmouth College · USThe Ohio State University · USUniversity of Miami · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
Mitochondrial metabolism in microbial sepsisR01GM135234 · NIGMS · OHIO STATE UNIVERSITY · PI WEN, HAITAO · 2019 to 2022
$1.2M
Regulation of mitochondrial function in T cellsR21AI110016 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI RINCON, MERCEDES · 2014 to 2015
$419k
IL-6 as a regulator of mitochondria function in T cellsR56AI116255 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI RINCON, MERCEDES · 2016 to 2016
$386k
NCI NIH HHS P30 CA016058NIAID NIH HHS R21 AI110016NIAID NIH HHS R56 AI116255NIGMS NIH HHS R01 GM135234
6 · The paper itself

Abstract

Interleukin 6 (IL-6) is known to regulate the CD4 T cell function by inducing gene expression of a number of cytokines through activation of Stat3 transcription factor. Here, we reveal that IL-6 strengthens the mechanics of CD4 T cells. The presence of IL-6 during activation of mouse and human CD4 T cells enhances their motility (random walk and exploratory spread), resulting in an increase in travel distance and higher velocity. This is an intrinsic effect of IL-6 on CD4 T-cell fitness that involves an increase in mitochondrial Ca

Indexed as

AnimalsCalciumCD4-Positive T-LymphocytesCell DifferentiationCell MovementCytokinesFemaleInterleukin-6Lymphocyte ActivationMaleMiceMice, Inbred C57BLMitochondriaSignal TransductionSTAT3 Transcription FactorCalciumCytokinesInterleukin-6interleukin-6, mouseStat3 protein, mouseSTAT3 Transcription FactorCD4 T cellsinterleukin-6mitochondrial calciummotilitySTAT3

Identifiers

PMID34507993
PMCPMC8449403
OpenAlexW3197550630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.